This is in line with all previous data, which corroborate the evidence that UniCAR T-cells undergo activation, release of pro-inflammatory cytokines, and killing of GRPR-expressing cancer cells exclusively in the presence of target cells and the respective BBN2 TMs. The gene discussed is GRPR; the disease is cancer.